SML2818
BAY-207
≥98% (HPLC)
别名:
N-(4-(3-Chlorophenoxy)-3-sulfamoylphenyl)-1-(2-chlorophenyl)cyclopropanecarboxamide
SMILES string
[S](=O)(=O)(N)c1c(ccc(c1)NC(=O)C4(CC4)c3c(cccc3)Cl)Oc2cc(ccc2)Cl
InChI key
JXAOITUGCKTSTF-UHFFFAOYSA-N
InChI
1S/C22H18Cl2N2O4S/c23-14-4-3-5-16(12-14)30-19-9-8-15(13-20(19)31(25,28)29)26-21(27)22(10-11-22)17-6-1-2-7-18(17)24/h1-9,12-13H,10-11H2,(H,26,27)(H2,25,28,29)
assay
≥98% (HPLC)
form
powder
color
white to beige
solubility
DMSO: 2 mg/mL, clear
storage temp.
2-8°C
Quality Level
Biochem/physiol Actions
BAY-207 is a negative control for a potent and selective P2X4 antagonist BAY-1797.
negative control for a potent and selective P2X4 antagonist BAY-1797
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
新产品
此项目有
Stefan Werner et al.
Journal of medicinal chemistry, 62(24), 11194-11217 (2019-11-21)
The P2X4 receptor is a ligand-gated ion channel that is expressed on a variety of cell types, especially those involved in inflammatory and immune processes. High-throughput screening led to a new class of P2X4 inhibitors with substantial CYP 3A4 induction
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持